Japan is leading the way in developing and taking Regenerative Medicine to market. Here is a pretty list of the players in this space.
I feel the the US will need to step up their game and compete with a fast tracked Japan.
MSB stands to attract increased interest from both the US and Japan with regard to their tier 1 and late stage products.
I place a speculative buy on MSB at these levels and will be buying! DYOR
Japanese Market participants
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.34 |
Change
0.050(3.89%) |
Mkt cap ! $1.501B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.34 | $1.30 | $1.228M | 934.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 91309 | $1.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.34 | 28253 | 5 |
View Market Depth
| Last trade - 12.46pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |